2013 ACR/ARHP Annual Meeting

October 25-30, 2013. San Diego, CA.

View by Title View Sessions

Jump to: View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z

Abstract Number: 2904

Gadolinium-Based Compounds Induce NLRP3-Dependent IL-1β Production and Peritoneal Inflammation
Abstract Number: 2205

Galectin-3 and Transforming Growth Factor-β Signaling In The Pathogenesis Of Coronary Artery Aneurysms In Kawasaki Disease
Abstract Number: 630

Galectin-3-Binding Protein Is Highly Increased On Circulating Microparticles In SLE Patients and Co-Localizes With IgG In Glomerular Deposits In Human Lupus Nephritis
Abstract Number: 1445

GEMS Audit: An Evaluation Of Routine Use Of Subcutaneous Methotrexate In Rheumatoid Arthritis
Abstract Number: 598

Gender Influence On Lupus Nephritis Outcomes In An Urban, Multiethnic Population
Abstract Number: 2012

Gender Influences On Organ Manifestations In a New Orleans Sarcoidosis Population
Abstract Number: 1767

Gender, Race, and Soluble Mediators Distinguish Blood Relatives Who Develop Incomplete Lupus Or Classified SLE In The Lupus Autoimmunity In Relatives (LAUREL) Study
Abstract Number: 1904

Gene Expression In Whole Blood Predicts The Abatacept–Methotrexate Combination Responsiveness In Rheumatoid Arthritis: Preliminary Results From The Power Doppler Ultrasonography IM101-179 Study
Abstract Number: 1488

Gene Expression Profile According To Systemic Disease Activity In Primary Sjögren’s Syndrome: Results From The Assessment Of Systemic Signs and Evolution Of Primary Sjögren’s Syndrome (ASSESS) Cohort
Abstract Number: 2865

Gene Expression Profiles Of Fibroblast-Like Synoviocytes In Early Stage Of Oligoarticular Juvenile Idiopathic Arthritis Are Different In Extended Versus Persistent Course
Abstract Number: 30

Gene Expression Profiling Analysis Of Human B-Cell Subsets In Health and Systemic Lupus Erythematosus
Abstract Number: 656

Gene Expression Variation and The Role Of Interferon In Patients With Morphea From The Morphea In Adults and Children Cohort
Abstract Number: 1872

Gene-Body Mass Index Interactions Are Associated With Methotrexate Toxicity in Rheumatoid Arthritis
Abstract Number: 1072

Gene-Environment Interaction Between HLA-DRB1 Shared Epitope and Occupational Textile Dust Exposure In The Risk Of ACPA-Positive Rheumatoid Arthritis In Female Patients: Evidence From The Malaysian Epidemiological Investigation Of Rheumatoid Arthritis Case-Control Study
Abstract Number: 1048

Generalizability Of a U.S. Rheumatoid Arthritis Registry: A Comparison Of Participants’ Vs. Non-Participants’ Characteristics
Abstract Number: 1005

Generalization and Extrapolation Of Treatment Effects From Clinical Studies In Rheumatoid Arthritis
Abstract Number: 1626

Genetic Alterations In Abnormal Neutrophils Isolated From Human Systemic Lupus Erythematosus Patients
Abstract Number: 1755

Genetic Association Of Mitochondrial DNA Polymorphisms With Behçet’s Disease In a Korean Population
Abstract Number: 174

Genetic Association On Disease Severity In Rheumatoid Arthritis: A Validation Study In Japanese Patients
Abstract Number: 1705

Genetic Associations In Anterior Uveitis Implicate T-Cell Co-Stimulation and Other Immune Pathways
Abstract Number: 1901

Genetic Variants In OPG and ANKH Are Associated With Severity Ofankylosis In Ankylosing Spondylitis In a Korean Cohort
Abstract Number: 2198

Genome Wide Association Meta-Analysis Implicates HLA-DRB1, The BTNL2/HLA-DRA region, and a Novel Susceptibility Locus On Chromosome 1 In Systemic Juvenile Idiopathic Arthritis
Abstract Number: 1889

Genome-Wide Association Study Of Knee Radiographic Osteoarthritis In African-American Populations
Abstract Number: 2773

Genome-Wide DNA Methylation Patterns In naïve CD4+ T Cells From Patients With Primary Sjögren’s Syndrome
Abstract Number: 1874

Genome-Wide Profiling Identifies Significant Differences Between The T-Lymphocyte and B-Lymphocyte Methylomes In Healthy Individuals
Abstract Number: 1634

Genome-Wide Transcriptional Profiling Of Isolated Immune Cell Populations From SLE Patients With Different Ancestral Backgrounds
Abstract Number: 162

Genotypic and Haplotypic Effects Of 7 Single-Nucleotide Polymorphisms In the CRP Gene On Levels Of C-Reactive Protein and DAS28 In a Cohort Of 180 Untreated Newly Diagnosed Rheumatoid Arthritis Patients (OPERA Study)
Abstract Number: 1993

Geographic Variations Of Gout Epidemiology In The United Kingdom: A Nationwide Population Study
Abstract Number: 2218

Gingival Stem Cells Suppress Osteoclast Formation and Bone Erosion In CIA Through CD39 Signal
Abstract Number: 87

Global and Country Specific Burden Of Musculoskeletal Disorders:a Report From The Global Burden Of Diseases Musculoskeletal Expert Group
Abstract Number: 1880

Global Gene Expression Profiles Reveal Genetic Signatures Of Kawasaki Disease and Disease Outcome
Abstract Number: 2290

Global Metabolite Profiling Of Synovial Fluids From Different Forms Of Inflammatory Arthritis For The Identification Of Putative Biomarker In Rheumatoid Arthritis
Abstract Number: 2099

Global Postural Reeducation To TREAT Chronic LOW Back PAIN: Randomized, Controlled Trial
Abstract Number: 55

Glucocorticoid Receptor Modulator Compound A Does Not Induce Leptin In Human Osteoarthritic Synovial Fibroblasts and In Dedifferentiated Chondrocytes
Abstract Number: 746

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
Abstract Number: 1052

Glucocorticosteroids and Mortality Risk In Rheumatoid Arthritis – Results Of a Population Based Study
Abstract Number: 2113

Glucosamine–Chondroitin Sulfate Reduces Pain, Disability and Non-Steroidal Anti-Inflammatory Drug consumption In Patients With Chronic Low Back Pain: A Large, Community-Based, Pilot, Open Prospective Study
Abstract Number: 281

GO-Kids Imaging Substudy: MRI Treatment Response To 30 Mg/m² 4-Weekly Subcutaneous injections Of Golimumab In Children With Polyarticular JIA – Preliminary Results Of The Open Label Portion
Abstract Number: 477

Golimumab Improves Patient-Reported Outcomes In Patients With Active Rheumatoid Arthritis
Abstract Number: 1456

Golimumab Levels, Anti-Drug Antibodies and Clinical Response In Rheumatoid Arthritis Patients At 28 Week Of Follow-Up
Abstract Number: 1544

Good Agreement Between The Ankylosing Spondylitis Disease Activity Scores Based On C-Reactive Protein and Erythrocyte Sedimentation Rate
Abstract Number: 2061

Good Inter-Rater Reliability Of Myositis Experts In Assessing Clinical Improvement
Abstract Number: 805

Good Response On Tumour Necrosis Factor Inhibitors Are Associated With a Decreased Risk Of Acute Coronary Syndromes In Patients With Rheumatoid Arthritis
Abstract Number: 2752

Good, Moderate and Poor Outcome Trajectories Of Pain Severity In Early Symptomatic Knee Osteoarthritis; 5 Year Follow-Up Of Check study
Abstract Number: 405

Gout and RA: Not Such a Rare Coexistence After All
Abstract Number: 1991

Gout In Ambulatory Care Settings In The US: 1993-2009
Abstract Number: 1197

Gout Medications and The Risk For Incident Coronary Heart Disease and Stroke: The Framingham Heart Study
Abstract Number: 2031

GRAID – Interim Analysis Of The Retrospective German Register In Autoimmune Diseases
Abstract Number: 741

Granulomatosis With Polyangiitis Central Nervous System Involvement: Presentation and Management
Abstract Number: 1273

Granulomatosis With Polyangiitis In Children Is More Severe Than In Adults. A Long-Term, Single Center, Follow Up Study
Abstract Number: 1714

Grey-Scale and Power Doppler Findings Of Lower Extremity Entheses In Healthy Children
Abstract Number: 651

Growth Differentation Factor-15, a Marker Of lung disease In Systemic Sclerosis, Is Involved In Fibrosis Development But Does Not Impair Fibrosis Development
Abstract Number: 1639

GWAS In Hispanic and Latin American Individuals Enriched For Amerindian Ancestry Identifies a New Locus Associated With Systemic Lupus Erythematosus

Jump to: View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].